Reporting On Acquisition Of Treasury Shares
| Date | # shares | Average price (in €) | Minimum price (in €) | Maximum price (in €) | Total value (in €) |
| 10/03/2025 | 34,000 | 8.435 | 8.380 | 8.470 | 286,785 |
| 11/03/2025 | 31,763 | 8.228 | 8.210 | 8.250 | 261,358 |
| 12/03/2025 | 37,093 | 8.256 | 8.210 | 8.290 | 306,249 |
| 13/03/2025 | 24,500 | 8.330 | 8.300 | 8.360 | 204,085 |
| 14/03/2025 | 15,326 | 8.602 | 8.400 | 8.670 | 131,834 |
On December 2, 2024 Ontex launched a share buy-back program to acquire a maximum of 1.5 million shares. The shares acquired will contribute to meeting Ontex's obligations under its current and future long-term incentive plans. The share purchases will be spread over a seven-month period ending on June 30, 2025. The program is conducted under the terms and conditions of the authorization granted by the extraordinary shareholders' meeting held on May 5, 2023, and is executed by an independent intermediary, who will make its decisions independently pursuant to a discretionary mandate.
Enquiries
- Investors Geoffroy Raskin +32 53 33 37 30 ... Media Catherine Weyne +32 53 33 36 22 ...
About Ontex
Ontex is a leading international developer and producer of baby, feminine and adult care products, both for retailers and the healthcare sector. Ontex's innovative products are distributed in around 100 countries through retailers and healthcare providers. Employing some 7,000 people, Ontex has a presence in 14 countries, with its headquarters in Aalst, Belgium. Ontex is listed on Euronext Brussel and is a constituent of the Bel Mid® index. To keep up with the latest news, visit ontex.com or follow Ontex on LinkedIn .
Attachment
-
250318_SBB_EN

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment